# Onivyde

NDC: 15054-0043
Generic name: IRINOTECAN HYDROCHLORIDE
Labeler / Manufacturer: Ipsen Biopharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, POWDER, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20151022

FDA application: NDA207793

## Active ingredients

- IRINOTECAN HYDROCHLORIDE: 4.3 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"15054-0043"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=15054-0043
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c8b58efa-1820-48a4-b70d-62918fc4abfc